Double Blind Placebo Controlled Bellis Perenis and Arnica Montana as a Drug for PPH

Hadassah Medical Center

Status and phase: Unknown; Phase 1

Conditions: Hemorrhage

Treatments: Drug: Bellis Perenis ,Arnica montana

Study type: Interventional

Funder types: Other

Identifiers

NCT00405626

Hompostpartum-HMO-CTIL

Details and patient eligibility

About

To look at the antihemmorhagic effect of 2 homeopathic drugs in women post delivery Bellis Perenis and Arnica montana

Full description

To look at the antihemmorhagic effect of 2 homeopathic drugs in women post delivery Bellis Perenis and Arnica montana compare it with placebo

Enrollment: 210 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• healthy women during delivery

Exclusion criteria

• Scarred uterus, multifetal ,multiparty,bleeding problems,cesarean sectons,chorioamnionitis

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind